Navigation Links
New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder

ssors experienced by women may contribute to a major depressive episode.

About Wyeth Pharmaceuticals

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements based on current expectations of future events and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include risks associated with the inherent uncertainty of the timing and success of product research, development and commercialization (including with respect to our pipeline products), drug pricing and payment for our products by government and third-party-payors, manufacturing, data generated on the safety and efficacy of our products, economic conditions including interest and currency exchange rate fluctuations, changes in generally accepted accounting principles, the impact of competitive or generic products, trade buying patterns, global business operations, product liability and other types of litigation, the impact of legislation and regulatory compliance, intellectual property rights, strategic relationships with third parties, environmental liabilities, and other risks and uncertainties, including those detailed from time to time in
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:6/2/2015)... 2, 2015 Thync today launched the ... in minutes; feeling more calm or energized when you need ... sleek and simple wearable is placed on the head and ... The neurosignaling device is operated with an accompanying app to ... your energy level. "Our mission at Thync ...
(Date:6/2/2015)... A new report by the ... million people across 13 countries bring an end to ... GSF,s latest Progress Report details how its financial support ... over 20,500 communities become open-defecation free, improved toilets for ... access to hand-washing facilities. The Progress Report ...
(Date:6/2/2015)... Los investigadores clínicos ... meses en la supervivencia libre de progresión en ... metastático inoperable (mCRC) tratados  en primera línea con ...    Los beneficios de añadir las ... con la quimioterapia sistémica actual para el tratamiento ...
Breaking Medicine Technology:Thync Launches First Wearable to Shift Your State of Mind 2Thync Launches First Wearable to Shift Your State of Mind 3Thync Launches First Wearable to Shift Your State of Mind 4Global Sanitation Fund Reports Major Sanitation & Hygiene Advances for Seven Million People in 13 Countries 2Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 2Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 3Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 4Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 5Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 6Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 7Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 8
... 2011 eCardio Diagnostics ( www.ecardio.com ) announced today ... an exclusive ranking of the nation,s fastest-growing private companies. ... #912 overall and #65 in the Health segment this ... The list represents the most comprehensive look at ...
... 24, 2011 "Production of Propofol was stopped after the ... Eglet attorney for the plaintiffs. In a stunning turn in ... Robert Eglet told the jury that production of the sedative ... million verdict in the Chanin trial in May 2010. Teva ...
Cached Medicine Technology:Inc. Magazine Unveils Its Annual Exclusive List of America's Fastest-Growing Private Companies—the Inc. 500|5000 22nd Day of Testimony: Mainor Eglet Attorney Continues Questioning Teva Pharmaceuticals Vice President 2
(Date:6/2/2015)... of Monarch Landing in Naperville are going to run ... yoga, play volleyball, or participate in whatever their exercise ... Walk to End Alzheimer’s on September 20 in Naperville, ... to exercise for 60 days, sponsored by Life Care ... walk will raise awareness of Alzheimer’s disease among the ...
(Date:6/2/2015)... TheCelebrityDresses.com, a popular online store selling celebrity ... summer fashion cocktail dresses. The company carries more than ... be suitable for a wide variety of summer events ... and make high quality trendy special occasion dresses ... quality satin, chiffon and cotton. Their products feature a ...
(Date:6/2/2015)... 02, 2015 Mercy Health (formerly Catholic ... and Kentucky – has devoted the seventh of its ... skin cancer prevention. One in five Americans will get ... Health’s YouTube channel, a Mercy Health expert addresses these ... main causes of skin cancer? ,     What are ...
(Date:6/2/2015)... CA (PRWEB) June 02, 2015 TranSlice: Reveal ... a new style. TranSlice: Reveal allows Final Cut Pro X ... growing lines to reveal their next screen. , TranSlice Reveal ... style. Final Cut Pro X users can now ... growing lines. , With every panel orientation and direction covered, ...
(Date:6/2/2015)... Consumer Reports, the world’s largest ... its commitment to help wipe out antibiotic-resistant bacteria ... antibiotics sicken about 2.25 million Americans each year ... Disease Control and Prevention. , The initiative kicks ... Tellado participating in the White House Forum on ...
Breaking Medicine News(10 mins):Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 2Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 3Health News:Video provides helpful information about skin cancer prevention 2Health News:Announcing the release of TranSlice Reveal from Pixel Film Studios - Professional Split Screen Transitions for FCPX. 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 3
... WASHINGTON, Oct. 28 Trust for America,s Health ... new ad campaign today entitled Health Care vs. Sick ... provides a once-in-a-lifetime chance to transform our health care system ... and wellness," said Jeff Levi, PhD, Executive Director of TFAH. ...
... experts say , WEDNESDAY, Oct. 28 (HealthDay News) -- Diet ... cutting the risk for the disease by more than a ... , About 11 percent of U.S. adults (24 million) have ... and sedentary lifestyle. In addition, 57 million overweight adults have ...
... given night, an estimated 43,000 people are homeless in Los Angeles, ... Homeless Report (HC09), released today by the Los ... Los Angeles, while still the highest in the nation, represents an ... data shows that a significant number of homeless in Los Angeles ...
... at risk, experts say , , WEDNESDAY, Oct. 28 ... urinary tract infections are commonly treated with preventive antibiotics, ... therapy may have at least a modest effect. ... the antibiotic combination of trimethoprim plus sulfamethoxazole (brand names ...
... ... , ... 2009 -- The Harvard Health Publications Division of Harvard Medical School has ... draws on the extensive knowledge of the experts at Harvard Medical School along with ...
... LPBP Inc. (the "Company") announces a correction to ... the per share dividend payable on the Class ... the Class B Non-Voting shares should have read ... shares of $0.0099 per share remains the same. ...
Cached Medicine News:Health News:New Health Care vs. Sick Care Ad Campaign Launched by Trust for America's Health and Partnership for Prevention 2Health News:New Health Care vs. Sick Care Ad Campaign Launched by Trust for America's Health and Partnership for Prevention 3Health News:Diet, Exercise Thwart Diabetes: Study 2Health News:Diet, Exercise Thwart Diabetes: Study 3Health News:New Census Reveals Decline in Greater Los Angeles Homelessness 2Health News:New Census Reveals Decline in Greater Los Angeles Homelessness 3Health News:New Census Reveals Decline in Greater Los Angeles Homelessness 4Health News:Preventive Antibiotics Help Some Kids Fend Off Urinary Infections 2Health News:Preventive Antibiotics Help Some Kids Fend Off Urinary Infections 3Health News:Harvard Health Publications Launches H1N1 Flu iPhone Application 2Health News:Harvard Health Publications Launches H1N1 Flu iPhone Application 3
All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheostat for fine control of il...
Pocket-sized instrument. All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheos...
Pocket-sized instrument with fiber optic illumination. Swivelling viewing window with 3X magnification....
All metal construction with fiber optic illumination. Large diameter viewing port, insufflation port, and swivelling airtight window....
Medicine Products: